Back to Search Start Over

Istari Oncology Announces New England Journal of Medicine Publication of Phase 1 Trial Results in Patients with Recurrent Glioblastoma Treated with PVSRIPO

Source :
Business Wire. June 26, 2018
Publication Year :
2018

Abstract

* 21% Overall Survival at 24 Months and 36 Months, Compared to 14% and 4% in Matched Historical Controls * PVSRIPO Granted Breakthrough Status and Orphan Status from the US [...]

Subjects

Subjects :
United States. Food and Drug Administration
Clinical trials
Periodical publishing -- Product development
Cancer research
Recurrence (Disease) -- Care and treatment
Immunotherapy
Glioblastomas -- Care and treatment
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.544382488

Tools

Authors Abstract Subjects Details